Different separation
techniques can be used to enrich certain particles (DNA, RNA, proteins,
organelles, vesicles, micelles, cells etc.) specifically from complex
biological mixtures such as cell and tissue homogenates, blood, urine
and other body fluids, so that they can then be selectively
investigated. Separation of these types of particles can be based either
on the different sedimentation rates of different particles in a fluid,
or on their different densities. Density gradient centrifugation (also
referred to as band, equilibrium or isopycnic centrifugation), exploits
the principle that particles of a certain density migrate into a density
gradient until they reach an equilibrium density layer. The first
applications of density gradient centrifugation were reported in the
early 1950s. Back then, cell organelles were enriched with the aid of
buffered saccharose gradients and it is uncontested that the knowledge
gained with these enriched materials made a contribution to modern
molecular biology. Soon it was discovered that the enrichment of
mammalian cells requires more complex separation media, particularly due
to their sensitivity towards osmotic fluctuation. Noble and Boyum
described methods for separating mononuclear cells from whole blood and
bone marrow as early as 1967 and 1968. Based on this pioneering
scientific work, numerous applications in today‘s biomedical research
and routine diagnostics require highly enriched, viable and functionally
intact cell populations as the starting material. The separation of
such cells by density gradient centrifugation has proven to be the most
often used method due to its uncomplicated and robust nature.
With Leucosep™, Greiner Bio-One optimised density gradient centrifugation whilst making it user-friendly. Alongside this, OncoQuick® was developed to extend the spectrum of applications to deal specifically with oncological targets.